← Evidence map

ArticleJAMA cardiology2017

Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans.

Dhruv S Kazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28903137